CN108451787B - Vitamin A alcohol-embedded nano lipid carrier and preparation method thereof - Google Patents
Vitamin A alcohol-embedded nano lipid carrier and preparation method thereof Download PDFInfo
- Publication number
- CN108451787B CN108451787B CN201810504590.XA CN201810504590A CN108451787B CN 108451787 B CN108451787 B CN 108451787B CN 201810504590 A CN201810504590 A CN 201810504590A CN 108451787 B CN108451787 B CN 108451787B
- Authority
- CN
- China
- Prior art keywords
- alcohol
- vitamin
- lipid carrier
- nano lipid
- embedded nano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 title claims abstract description 104
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 title claims abstract description 69
- 150000002632 lipids Chemical class 0.000 title claims abstract description 57
- 229940045997 vitamin a Drugs 0.000 title claims abstract description 43
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 title claims abstract description 34
- 235000019155 vitamin A Nutrition 0.000 title claims abstract description 34
- 239000011719 vitamin A Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000019169 all-trans-retinol Nutrition 0.000 claims abstract description 33
- 239000011717 all-trans-retinol Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 14
- 239000004203 carnauba wax Substances 0.000 claims abstract description 13
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims description 30
- 235000019198 oils Nutrition 0.000 claims description 30
- 239000002245 particle Substances 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 5
- 229940073499 decyl glucoside Drugs 0.000 claims description 5
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000008236 heating water Substances 0.000 claims description 5
- 235000012424 soybean oil Nutrition 0.000 claims description 5
- 239000003549 soybean oil Substances 0.000 claims description 5
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 claims description 4
- 229920001993 poloxamer 188 Polymers 0.000 claims description 4
- 229940044519 poloxamer 188 Drugs 0.000 claims description 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229940068968 polysorbate 80 Drugs 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 2
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 229940083466 soybean lecithin Drugs 0.000 claims description 2
- 230000007794 irritation Effects 0.000 abstract description 9
- 244000046052 Phaseolus vulgaris Species 0.000 abstract description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract description 6
- 230000000694 effects Effects 0.000 description 14
- 239000001993 wax Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- 238000009826 distribution Methods 0.000 description 6
- 235000019493 Macadamia oil Nutrition 0.000 description 5
- 230000002776 aggregation Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000010469 macadamia oil Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000005054 agglomeration Methods 0.000 description 4
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241001071905 Echium Species 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229940094199 black currant oil Drugs 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229960000342 retinol acetate Drugs 0.000 description 3
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 3
- 235000019173 retinyl acetate Nutrition 0.000 description 3
- 239000011770 retinyl acetate Substances 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000021319 Palmitoleic acid Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical group CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 108010071421 milk fat globule Proteins 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
- A61K2800/72—Hypo-allergenic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a vitamin A alcohol-embedded nano lipid carrier and a preparation method thereof, relates to the field of skin care products, and solves the problems of high irritation and poor stability when vitamin A alcohol is directly applied to skin care products, wherein the vitamin A alcohol-embedded nano lipid carrier comprises the following components, by weight, 8 ~% of Hawaii bean oil, 8 ~% of palm wax, 1 ~% of vitamin A alcohol, 8 ~% of a non-ionic surfactant, 1 ~% of an alcohol solvent, 0.1 ~% of phospholipid and the balance of water.
Description
Technical Field
The invention relates to the field of skin care products, in particular to a vitamin A alcohol-embedded nano lipid carrier and a preparation method thereof.
Background
The vitamin A is A acid, A ester and A alcohol respectively, and has the main effects of removing wrinkles, resisting aging, improving rough skin, smoothing skin, enhancing the metabolic function of skin, promoting cuticle exfoliation and resisting aging. Because A acid can irritate skin when directly used, if vitamin A is used for skin care, A alcohol and A ester are used as main components, once the alcohol or ester is absorbed by skin, the vitamin A can be converted into A acid to achieve the effect of skin care, because the vitamin A can absorb light, the vitamin A is easy to deteriorate due to light irradiation and also deteriorate due to oxidation, the vitamin A needs to be protected, and if the vitamin A is used for skin protection, carrier embedding is a good choice, wherein a lipid carrier is the most excellent.
In chinese patent publication No. CN101884416A, a method for embedding vitamin a acetate is disclosed, in which milk fat globule membrane phospholipid, cholesterol, vitamin E and vitamin a acetate are mixed and then added with absolute ethanol, and then treated with a rotary evaporator, a high-speed shear and a high-pressure homogenizer respectively to obtain vitamin a acetate liposome.
The above patent, while capable of entrapping vitamin a, is used to provide different nutrition to consumers and cannot be used in skin care products. At present, the research of embedding vitamin A alcohol by adopting a nano lipid carrier and applying the vitamin A alcohol to skin care products is not reported.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a vitamin A alcohol-embedded nano lipid carrier, which is used for embedding vitamin A alcohol by matching Hawaii soybean oil, palm wax and a surfactant, and has the advantages of high embedding rate, good stability and low irritation.
In order to achieve the first purpose, the invention provides the following technical scheme:
a nanometer lipid carrier for embedding vitamin A alcohol comprises the following components in percentage by weight:
8-12% of Hawaii bean oil;
8-12% of palm wax;
1-5% of vitamin A alcohol;
8-12% of a nonionic surfactant;
1-3% of an alcohol solvent;
0.1-1% of phospholipid;
the balance being water.
By adopting the technical scheme, the components of the vitamin A alcohol embedded in the nano lipid carrier mainly comprise oil, wax, surfactant, water and the like, and the currently common oil comprises natural and synthetic oil, wherein the natural oil comprises black currant oil, echium oil, mineral oil, wheat germ oil and the like, and the common solid wax comprises solid oil palm wax, ATO888, honey wax and the like. Although common natural oils such as blackcurrant oil and echium oil have a skin-protecting effect, they contain unsaturated fatty acids, and therefore, if they are stored improperly, they are easily oxidized, which affects the application of skin care products, and at the same time, the prices of blackcurrant oil and echium oil are high, which is not suitable for commercialization.
Hawaii bean oil contains mineral, protein, unit and polyunsaturated fatty acid, and mainly contains oleic acid, palmitoleic acid, linoleic acid, linolenic acid and triglyceride. Wherein, oleic acid has the effects of moisturizing and resisting aging, and palmitoleic acid is an essential fatty acid, has the functions of skin-friendly and skin-moistening, and is an indispensable component for delaying skin and cell aging.
The macadamia oil has similar components to the oil secreted by sebaceous glands in vivo, and the main fatty acid contained in the macadamia oil has the characteristic of protecting the skin. On the other hand, the palm wax can adjust the consistency of oily products, can increase the skin luster and has a moistening effect on the skin. The main functions of the phospholipid are to increase the stability and the permeability of the vitamin A alcohol, promote the recovery of cells and effectively improve the capability of repairing skin. The compounding of the nonionic surfactant and the phospholipid can fully emulsify the water phase and the oil phase and avoid the agglomeration of particles.
Through a large number of experiments, the inventor selects the components to be matched with the embedded vitamin A alcohol, the embedding rate is close to 100%, the stability is good, and the irritation is low.
More preferably, the nonionic surfactant is any one selected from decyl glucoside, polysorbate-80, and poloxamer 188.
By adopting the technical scheme, poloxamer 188 can form a stereoscopic effect, so that particle agglomeration is avoided; decyl glucoside is a mild nonionic surfactant, can not cause dry and astringent feeling on skin, and has the characteristics of easy biodegradation, extreme mildness, no irritation, low toxicity and the like.
More preferably, the alcohol solvent is any one selected from propylene glycol, butylene glycol and pentylene glycol.
More preferably, the phospholipid is selected from any one of egg yolk lecithin, soybean lecithin and hydrogenated lecithin.
By adopting the technical scheme, the lecithin is one of the components forming the cell membrane, the three phospholipids can increase the stability and the permeability of the vitamin A alcohol, and the yolk lecithin has the best effect. The lecithin-coated product can also obviously reduce the water loss capacity of the skin after long-term use, thereby achieving the effects of water locking and moisture retention.
The second purpose of the invention is to provide a preparation method of the vitamin A alcohol-embedded nano lipid carrier, and the nano lipid carrier prepared by the method has the advantages of high embedding rate, good stability and low irritation.
In order to achieve the second purpose, the invention provides the following technical scheme:
a preparation method of a vitamin A alcohol-embedded nano lipid carrier comprises the following steps:
step one, mixing Hawaii bean oil and palm wax, heating to 85-90 ℃ at constant temperature, adding vitamin A alcohol, and uniformly mixing to form an oil phase;
step two, heating water, an alcohol solvent, a non-ionic surfactant and phospholipid to 85-90 ℃ at constant temperature to form a water phase;
adding the oil phase into the water phase, uniformly mixing, and keeping the temperature to 85-90 ℃ to form a mixed phase;
pre-emulsifying the mixed phase by using a homogenizer at the rotation speed of 8000rpm to form mixed phase emulsion;
and step five, feeding the mixed phase emulsion into a high-pressure homogenizer, pressurizing to 600bar in the high-pressure homogenizer, and circulating for 3 times to obtain the vitamin A alcohol-embedded nano lipid carrier.
By adopting the technical scheme, in order to reduce the irritation of the vitamin A alcohol and avoid oxidation, the nano lipid carrier embedded vitamin A alcohol is prepared by adopting a thermal emulsification high-pressure homogenization method, so that the embedding rate and stability can be improved, and the situation that the lipid forms complete lattices and extrudes the medicament is avoided. The periphery of the vitamin A alcohol is coated by wax, so that the medicine can be effectively released, the medicine leakage is reduced, and the irritation to the skin is reduced.
More preferably, the particle size of the vitamin A alcohol-embedded nano lipid carrier is 200-400 nm.
By adopting the technical scheme, the nano lipid carrier prepared by the invention has small particle size, increases the contact area between skin and skin care products, and has the effect of preventing moisture from losing from the skin, and the lipophilic coating outer membrane adopted by the nano lipid carrier can effectively isolate active ingredients from external unstable factors, strengthens skin-friendly property, enables the active ingredients to accurately reach the bottom layer of the skin, continuously releases the active ingredients and provides the most complete nutrients for the skin. The nano lipid carrier has a shielding effect, and for lipid carriers with the particle size of 200nm and 2 μm, the water is easy to evaporate because the holes among large particles are relatively large and the shielding rate is only 20%, while the holes among small particles are relatively small and the shielding rate can reach 60%, so the water is not easy to evaporate, and the smaller the particles are, the stronger the adhesive force is, and the better the shielding effect is.
More preferably, the embedding rate of the vitamin A alcohol-embedded nano lipid carrier is more than 86%.
By adopting the technical scheme, the proportion of the wax in the invention is 8-12%, and the vitamin A alcohol is far higher than 3%, and the vitamin A alcohol is fat-soluble, so the vitamin A alcohol can be effectively dissolved in the mixed emulsion of the oil and the wax, and has higher embedding rate.
More preferably, the interfacial potential of the vitamin A alcohol-embedded nano lipid carrier is-33 to-49 mV.
By adopting the technical scheme, the physical stability can be evaluated by measuring the interface potential, and generally when the interface potential is more than |30| mV, the system belongs to a stable state, the aggregation of the particles is low, and the main reason is that electrostatic repulsion exists between the particles. When the interface potential is between |15| - |30| mV, it indicates that the system has the possibility of agglomeration, when the interface potential is higher than |60| mV, the system has extremely high stability, and when the interface potential is lower than |5| mV, it indicates that the system has the possibility of serious agglomeration. The interfacial potential value of the nano lipid carrier prepared by the invention is-33 mV to-49 mV, which shows that the nano lipid carrier has good stability and dispersibility.
The addition amount of the skin care product is 5-10%.
In summary, compared with the prior art, the invention has the following beneficial effects:
(1) according to the invention, raw materials such as Hawaii bean oil, palm wax and surfactant are mutually matched to embed vitamin A alcohol, and the vitamin A alcohol-embedded nano lipid carrier is applied to skin care products, so that the skin care products have the advantages of low irritation, good drug release and the like, and the oxidation of the vitamin A alcohol is avoided;
(2) the embedding system can well embed vitamin A alcohol, and the embedding rate is close to 100%;
(3) the interface potential value of the nano lipid carrier prepared by the invention is-33 mV to-49 mV, and the nano lipid carrier has good stability and dispersibility.
Drawings
FIG. 1 is a flow chart of the preparation of the present invention.
Detailed Description
The invention is described in detail below with reference to the figures and examples.
Example 1: the vitamin A alcohol-embedded nano lipid carrier comprises the components and the corresponding weight percentage shown in the table 1, and the preparation flow refers to the figure 1 and is prepared by the following steps:
step one, mixing Hawaii bean oil and palm wax, heating to 85 ℃ at constant temperature, adding vitamin A alcohol, and uniformly mixing to form an oil phase;
step two, heating water, an alcohol solvent, a non-ionic surfactant and phospholipid to 85 ℃ at constant temperature to form a water phase;
adding the oil phase into the water phase, uniformly mixing, and keeping the temperature to 85 ℃ to form a mixed phase;
pre-emulsifying the mixed phase by using a homogenizer at the rotation speed of 8000rpm for 30min to form mixed phase emulsion;
and step five, feeding the mixed phase emulsion into a high-pressure homogenizer, pressurizing to 600bar in the high-pressure homogenizer, and circulating for 3 times to obtain the vitamin A alcohol-embedded nano lipid carrier.
Examples 2 to 9: a vitamin a alcohol-embedded nano lipid carrier, which is different from example 1 in that each component and the corresponding weight percentage thereof are shown in table 1.
TABLE 1 Components and weight percentages of examples 1-9
Examples 10 to 19: a vitamin a alcohol-embedded nano lipid carrier, which is different from example 1 in that each component and the corresponding weight percentage thereof are shown in table 2.
TABLE 2 Components and weight percentages of examples 10-19
Example 20: a vitamin a alcohol-embedded nano lipid carrier, which is different from example 1 in that the preparation method comprises the following steps:
step one, mixing Hawaii soybean oil and palm wax, heating to88 ℃ at constant temperature, adding vitamin A alcohol, and uniformly mixing to form an oil phase;
step two, heating water, an alcohol solvent, a non-ionic surfactant and phospholipid to88 ℃ at constant temperature to form a water phase;
adding the oil phase into the water phase, uniformly mixing, and keeping the temperature to88 ℃ to form a mixed phase;
pre-emulsifying the mixed phase by using a homogenizer at the rotation speed of 8000rpm for 35min to form mixed phase emulsion;
and step five, feeding the mixed phase emulsion into a high-pressure homogenizer, pressurizing to 600bar in the high-pressure homogenizer, and circulating for 3 times to obtain the vitamin A alcohol-embedded nano lipid carrier.
Example 21: a vitamin a alcohol-embedded nano lipid carrier, which is different from example 1 in that the preparation method comprises the following steps:
step one, mixing Hawaii soybean oil and palm wax, heating to 90 ℃ at constant temperature, adding vitamin A alcohol, and uniformly mixing to form an oil phase;
step two, heating water, an alcohol solvent, a non-ionic surfactant and phospholipid to 90 ℃ at constant temperature to form a water phase;
adding the oil phase into the water phase, uniformly mixing, and keeping the temperature to 90 ℃ to form a mixed phase;
pre-emulsifying the mixed phase by using a homogenizer at the rotation speed of 8000rpm for 40min to form mixed phase emulsion;
and step five, feeding the mixed phase emulsion into a high-pressure homogenizer, pressurizing to 600bar in the high-pressure homogenizer, and circulating for 3 times to obtain the vitamin A alcohol-embedded nano lipid carrier.
Comparative example 1: a nano lipid carrier for embedding vitamin a alcohol, which is different from the nano lipid carrier in example 1 in that macadamia oil is replaced by wheat germ oil with equal weight percentage.
Comparative example 2: a vitamin a alcohol-embedded nano lipid carrier, which is different from example 1 in that palm wax is replaced with castor wax in an equal weight percentage.
Comparative example 3: a vitamin a alcohol-embedded nano lipid carrier, which is different from that of example 1 in that decyl glucoside is replaced by sodium dodecyl sulfate in equal weight percentage.
In order to determine the oil concentration, wax concentration and surfactant most suitable for preparing the retinol-embedded nano lipid carrier, the inventors set the oil concentration, wax concentration, surfactant type and surfactant concentration as the condition factors of the experiment and collated them as listed in table 3.
TABLE 3 Condition factor leveling Table
Condition factor | 1 | 2 | 3 |
(A) Oil concentration | 8 | 10 | 12 |
(B) Wax concentration | 12 | 10 | 8 |
(C) Surfactant species | Decyl glucoside | Polysorbate-80 | Poloxamer 188 |
(D) Surfactant concentration | 8% | 10% | 12% |
According to the condition factors in table 3, 9 samples of the vitamin a alcohol-embedded nano lipid carrier were obtained by combining different conditions using the kou method, and the 9 samples were arranged in table 4.
Table 4 experimental design orthogonal meter
Since the particle size and the polydispersity index (PDI) affect the physical stability, drug release, and chemical stability of a sample, they can be important indicators of stability. Table 5 shows the particle size variation of the retinol-embedded nano-lipid carrier measured and recorded at different times, with a measurement temperature of 5 ℃.
The particle size of the sample prepared in the first day is about 200-400 nm, the particle size changes stably after thirty days due to different operating conditions.
The PDI value can be known to the distribution situation of the particle size, when the PDI is less than 0.05, the particle size is in a single distribution, when the PDI is less than 0.08, the particle size is in a nearly single distribution, when the PDI is between 0.08 and 0.7, the particle size is in a moderate dispersion system, and when the PDI is more than 0.7, the particle size is in a multi-distribution system. Table 6 shows the PDI change data at different times and the test temperature is 5 ℃. The PDI value of the sample obtained by the method is about 0.3-0.80 in the first day, so that the nano lipid carrier prepared by the method is a moderate dispersion system, and the PDI of most samples is maintained between 0.3-0.6 after thirty days of storage, so that the particle sizes of the samples are quite consistent.
TABLE 5 mean particle size measurement data of retinol-embedded nano-lipid carrier at different storage time
TABLE 6 polydispersity index (PDI) assay data for retinol-embedded nanoliposome carriers at different storage times
Table 7 shows the interfacial potentials measured at different times in the respective sets of experiments, at a test temperature of 5 ℃ and from the results measured on the first day, the distribution of the interfacial potentials was-33 mV to-49 mV, indicating that the interfacial potentials had an effect on the interfacial potentials under different conditions, and the interfacial potentials were mostly-30 mV or more except No.4 for 30 days of storage, so that the absolute values were all larger than 30mV, indicating that the dispersibility of the nano-lipid carrier prepared thereby was good. The interface potential values of the prepared samples are about-30 mV to-50 mV, which belong to a particle dispersion state with good stability, and the samples prepared by the method have good dispersibility and belong to a stable colloid distribution state.
TABLE 7 interfacial potential detection data of vitamin A alcohol-embedded nano lipid carrier at different storage times
Corresponding embodiment | Group of | Day 1 (mV) | Day 10 (mV) | Day 20 (mV) | Day 30 (mV) |
1 | NO.1 | -49.1±0.85 | -48.4±0.41 | -45.6±0.814 | -44.2±0.723 |
2 | NO.2 | -34.3±0.45 | -43.2±0.81 | -29.1±0.912 | -29.9±1.55 |
3 | NO.3 | -33.7±1.22 | -29.5±1.18 | -34.7±2.08 | -30.1±0.931 |
4 | NO.4 | -33.8±0.34 | -32.5±1.01 | -35.2±1.31 | -30.5±0.922 |
5 | NO.5 | -35.1±0.31 | -31.9±0.62 | -36.2±0.801 | -17.6±1.55 |
6 | NO.6 | -35.5±1.71 | -34.8±0.35 | -28.5±1.14 | -29.4±0.48 |
7 | NO.7 | -33.7±0.86 | -28.1±0.39 | -29.3±1.61 | -34.1±2.53 |
8 | NO.8 | -36.0±0.81 | -33.1±1.15 | -37.3±1.45 | -34.3±1.56 |
9 | NO.9 | -37.6±0.77 | -38.5±1.40 | -36.1±0.82 | -41.6±1.53 |
The material structure is changed along with the change of the temperature, and the nano-lipid changes the crystal structure when the nano-lipid carrier is prepared by using a hot high-pressure homogenization method. The crystallinity analysis was performed on the 9 samples using differential scanning calorimetry, and the relevant analytical data were collated as table 8. As can be seen from table 8, the crystallinity was reduced when macadamia oil was added, since the crystal arrangement was incomplete due to the addition of macadamia oil, and the smaller the crystallinity, the larger the space of the crystal lattice for coating vitamin a alcohol.
TABLE 8 crystallinity of retinol-embedded nanolipid carrier samples
To find out how the embedding effect is, table 9 shows the data of the embedding rate of the vitamin a alcohol-embedded nano lipid carrier. As can be seen from table 9, the results showed that the entrapment rate was close to 100%, indicating that the lipid carrier had an excellent entrapment effect for retinol. One is that the crystallinity is less than 20%, and the nano-lipid carrier structure has a large embedding space; secondly, the proportion of the wax in the invention is 8-12%, which is much higher than 3% of vitamin A alcohol, and because the vitamin A alcohol is fat-soluble, the vitamin A alcohol can be effectively dissolved in the mixed emulsion of oil and wax, thereby having higher embedding rate.
TABLE 9 detection data of embedding rate of vitamin A alcohol-embedded nano lipid carrier
The samples obtained from examples 1-21 and comparative examples 1-3 were tested for skin irritation according to the test method in chapter 4, section sixth of the technical specifications for cosmetic safety 2015 edition. The results of the skin irritation test are shown in Table 10. from Table 10, it can be seen that, although examples 8, 18 and 19 are slightly irritating, the examples are non-irritating, and comparative examples 1 to 3 are moderately irritating, which indicates that the embedding system of the present invention can embed retinol well, and the components have good compatibility with each other, and can reduce irritation.
Table 10 skin irritation test results
The above description is only a preferred embodiment of the present invention, and the protection scope of the present invention is not limited to the above embodiments, and all technical solutions belonging to the idea of the present invention belong to the protection scope of the present invention. It should be noted that modifications and embellishments within the scope of the invention may occur to those skilled in the art without departing from the principle of the invention, and are considered to be within the scope of the invention.
Claims (5)
1. The vitamin A alcohol-embedded nano lipid carrier is characterized by comprising the following components in percentage by weight:
hawaii soybean oil 8 ~ 12%;
8% of palm wax, 8 ~ 12%;
vitamin a alcohol 1 ~ 5%;
8% of nonionic surfactant 8 ~ 12%;
alcohol solvent 1 ~ 3%;
0.1 ~ 1% of phospholipid;
the balance of water;
the nonionic surfactant is any one of decyl glucoside, polysorbate-80 and poloxamer 188;
the phospholipid is selected from any one of egg yolk lecithin, soybean lecithin and hydrogenated lecithin;
the preparation method of the vitamin A alcohol-embedded nano lipid carrier comprises the following steps:
step one, mixing Hawaii soybean oil and palm wax, heating to 85 ~ 90 ℃ at constant temperature, adding vitamin A alcohol, and mixing uniformly to form an oil phase;
step two, heating water, alcohol solvent, nonionic surfactant and phospholipid to 85 ~ 90 ℃ at constant temperature to form a water phase;
adding the oil phase into the water phase, uniformly mixing, and keeping the temperature to 85 ~ 90 ℃ to form a mixed phase;
pre-emulsifying the mixed phase by using a homogenizer at the rotation speed of 8000rpm to form mixed phase emulsion;
and step five, feeding the mixed phase emulsion into a high-pressure homogenizer, pressurizing to 600bar in the high-pressure homogenizer, and circulating for 3 times to obtain the vitamin A alcohol-embedded nano lipid carrier.
2. The vitamin A alcohol-embedded nano lipid carrier as claimed in claim 1, wherein the alcohol solvent is selected from any one of propylene glycol, butylene glycol and pentylene glycol.
3. The vitamin A alcohol embedded nano lipid carrier as claimed in claim 1, wherein the particle size of the vitamin A alcohol embedded nano lipid carrier is 200 ~ 400 nm.
4. The vitamin A alcohol-embedded nano lipid carrier according to claim 1, wherein the embedding rate of the vitamin A alcohol-embedded nano lipid carrier is more than 86%.
5. The vitamin A alcohol-embedded nano lipid carrier according to claim 1, wherein the interface potential of the vitamin A alcohol-embedded nano lipid carrier is-33 ~ -49 mV.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810504590.XA CN108451787B (en) | 2018-05-23 | 2018-05-23 | Vitamin A alcohol-embedded nano lipid carrier and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810504590.XA CN108451787B (en) | 2018-05-23 | 2018-05-23 | Vitamin A alcohol-embedded nano lipid carrier and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108451787A CN108451787A (en) | 2018-08-28 |
CN108451787B true CN108451787B (en) | 2020-01-07 |
Family
ID=63214532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810504590.XA Expired - Fee Related CN108451787B (en) | 2018-05-23 | 2018-05-23 | Vitamin A alcohol-embedded nano lipid carrier and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108451787B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110786512B (en) * | 2019-10-17 | 2023-08-11 | 东北农业大学 | Grease liposome and preparation method thereof |
CN111228136A (en) * | 2020-03-09 | 2020-06-05 | 湖州浦瑞生物医药技术有限公司 | Anti-aging wrinkle-removing composite nano preparation and preparation method and application thereof |
CN111249185A (en) * | 2020-03-19 | 2020-06-09 | 上海格兰化妆品有限公司 | Nano lipid carrier for embedding idebene and preparation method and application thereof |
CN111358734A (en) * | 2020-04-10 | 2020-07-03 | 上海新高姿化妆品有限公司 | A warehouse-separated anti-aging cosmetic composition |
CN111920702A (en) * | 2020-08-21 | 2020-11-13 | 上海益好纳米科技有限公司 | Retinol nano liposome and preparation method thereof |
CN113304069A (en) * | 2021-06-01 | 2021-08-27 | 栈秋(上海)化妆品有限公司 | Retinol nanocrystalline wrap and preparation method thereof |
CN116019738B (en) * | 2022-12-27 | 2024-02-20 | 海雅美生物技术(珠海)有限公司 | Retinol inclusion for skin care product and preparation method and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101370453A (en) * | 2005-12-14 | 2009-02-18 | 扎尔斯制药公司 | Compositions and methods for dermal delivery of drugs |
JP2009234951A (en) * | 2008-03-26 | 2009-10-15 | Univ Kanagawa | Cosmetic and method for producing the same |
CN103070390A (en) * | 2011-10-26 | 2013-05-01 | 丰益(上海)生物技术研发中心有限公司 | Nano-liposome carrier composition and preparation method thereof |
WO2015155639A1 (en) * | 2014-04-08 | 2015-10-15 | Red Gold Agarose Corp. | A gel-like agarose admixture for intermediate cosmetics product |
CN105496801A (en) * | 2016-01-19 | 2016-04-20 | 上海应用技术学院 | Nanostructured solid lipid carrier coating vitamin A palmitate and preparation method thereof |
CN105496802A (en) * | 2016-01-19 | 2016-04-20 | 上海应用技术学院 | Vitamin E acetate-coated nanometer solid lipid carrier and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102099011B (en) * | 2009-07-09 | 2016-06-01 | 奥莎迪药品管理有限公司 | Matrix carriei composition, method and purposes |
FR2991172A1 (en) * | 2012-06-01 | 2013-12-06 | Galderma Res & Dev | TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING MICROCAPSULES |
TWI728957B (en) * | 2014-10-31 | 2021-06-01 | 美商盧伯利索先進材料有限公司 | Thermoplastic polyurethane film for delivery of active agents to skin surfaces and use and forming method thereof |
WO2017185147A1 (en) * | 2016-04-25 | 2017-11-02 | L'oreal | Nanostructured lipid carriers and methods for making and using them |
-
2018
- 2018-05-23 CN CN201810504590.XA patent/CN108451787B/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101370453A (en) * | 2005-12-14 | 2009-02-18 | 扎尔斯制药公司 | Compositions and methods for dermal delivery of drugs |
JP2009234951A (en) * | 2008-03-26 | 2009-10-15 | Univ Kanagawa | Cosmetic and method for producing the same |
CN103070390A (en) * | 2011-10-26 | 2013-05-01 | 丰益(上海)生物技术研发中心有限公司 | Nano-liposome carrier composition and preparation method thereof |
WO2015155639A1 (en) * | 2014-04-08 | 2015-10-15 | Red Gold Agarose Corp. | A gel-like agarose admixture for intermediate cosmetics product |
CN105496801A (en) * | 2016-01-19 | 2016-04-20 | 上海应用技术学院 | Nanostructured solid lipid carrier coating vitamin A palmitate and preparation method thereof |
CN105496802A (en) * | 2016-01-19 | 2016-04-20 | 上海应用技术学院 | Vitamin E acetate-coated nanometer solid lipid carrier and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
A robust experimental design method to optimize formulations of retinol solid lipid nanoparticles;Youn Jung Jung et.al;《Journal of Microencapsulation》;20131231;第30卷(第1期);第2页右栏Preparation of SLN,第5页右栏第3段 * |
Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids;Volkhard Jenning et.al;《international journal of pharmaceutics》;20001231;第199卷;第168页2.2部分 * |
Also Published As
Publication number | Publication date |
---|---|
CN108451787A (en) | 2018-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108451787B (en) | Vitamin A alcohol-embedded nano lipid carrier and preparation method thereof | |
TWI797071B (en) | Hair growth composition and method | |
CN101484121B (en) | Macro-sized lipid capsule emulsion composition and cosmetic composition containing the same | |
KR20160093065A (en) | Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics | |
CN104000747A (en) | Liquid crystal emulsification gel composition and mask | |
KR102122839B1 (en) | Multilamellar vesicle containing retinaldehyde and cosmetic composition comprising thereof | |
CN104918600B (en) | Emulsion compositions and application thereof | |
CN110075018B (en) | Hair care composition micro-nano emulsion containing tea polyphenol and fibroin and preparation method thereof | |
CN109276483B (en) | Plukenetia volubilis linneo oil microemulsion and preparation method thereof | |
CN112675079B (en) | Quick-emulsifying cleansing oil | |
CN106726770A (en) | A kind of makeup removing micelle composition and preparation method thereof and the application in makeup remover | |
CN104784074B (en) | A kind of cation nanometer emulsion with antiallergic effect and preparation method thereof | |
Wuttikul et al. | Formation of microemulsions for using as cosmeceutical delivery systems: effects of various components and characteristics of some formulations | |
CN106061462B (en) | Ceramide dispersive composition | |
Rosli et al. | Formulation and characterization of nanostructured lipid carrier encapsulated Zingiber zerumbet oil using ultrasonication technique | |
WO2012089184A2 (en) | Colloidal carrier system with penetration properties for encapsulating lipophilic active agents and oils for topical use | |
CN115252516A (en) | Water-feeling blush and preparation method thereof | |
KR101868481B1 (en) | Cosmetic composition for moisturizing skin with snowflake pattern and method of thereof | |
CN108498450A (en) | A kind of high osmosis moisture saver mask and preparation method thereof | |
KR100904370B1 (en) | Cosmetic Composition containing Nanoliposomes | |
CN111249174A (en) | Double-shell-core structure composition and preparation method thereof | |
CN116236402A (en) | Nanometer liposome particle for wrapping active ingredient, and preparation method and application thereof | |
CN115429713A (en) | Moisturizing, repairing and anti-aging composition containing ceramide and preparation method thereof | |
CN108888570A (en) | A kind of mild emulsifier that salt resistant character is good | |
TW201900153A (en) | Emulsified liposome composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200107 |